Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1

Stem Cells

Volumn 34, Issue 10, 2016, Pages 2536-2547

  Barcellos de Souza, Pedro ^a,b   Comito, Giuseppina ^a   Pons Segura, Coral ^a   Taddei, Maria Letizia ^a   Gori, Valentina ^c   Becherucci, Valentina ^c   Bambi, Franco ^c   Margheri, Francesca ^a   Laurenzana, Anna ^a   Del Rosso, Mario ^a   Chiarugi, Paola ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b MINISTRY OF EDUCATION OF BRAZIL   (Brazil)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Bone derived mesenchymal stem cells; Carcinoma associated fibroblast; Carcinoma associated macrophages; Prostate cancer; TGF ; Tumor microenvironment

Indexed keywords

ACTIN; ALPHA SMOOTH MUSCLE ACTIN; CELL MARKER; FIBROBLAST ACTIVATION PROTEIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CARCINOMA ASSOCIATED FIBROBLAST; CARCINOMA CELL; CELL ACTIVATION; CELL POLARITY; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; FIBROBLAST; HUMAN; HUMAN CELL; MACROPHAGE; MALE; MESENCHYMAL STEM CELL; MONOCYTE; PHENOTYPE; PROSTATE CARCINOMA; PROTEIN EXPRESSION; STEM CELL MOBILIZATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR INVASION; TUMOR MICROENVIRONMENT;

EID: 84990838759     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2412     Document Type: Article

References (57)

1. Dvorak HF. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315:1650–1659.
2. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011;144:646–674.
3. Chiarugi P. Cancer-associated fibroblasts and macrophages: Friendly conspirators for malignancy. Oncoimmunology 2013;2:e25563.
4. Giannoni E, Bianchini F, Masieri L et al. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res 2010;70:6945–6956.
5. Kalluri R Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006;6:392–401.
6. Cirri P Chiarugi P. Cancer-associated-fibroblasts and tumour cells: A diabolic liaison driving cancer progression. Cancer Metastasis Rev 2012;31:195–208.
7. Giannoni E, Bianchini F, Calorini L et al. Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. Antioxid Redox Signal 2011;14:2361–2371.
8. Fiaschi T, Marini A, Giannoni E et al. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res 2012;72:5130–5140.
9. Mantovani A, Biswas SK, Galdiero MR et al. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013;229:176–185.
10. Sica A, Mantovani A. Macrophage plasticity and polarization: In vivo veritas. J Clin Invest 2012;122:787–795.
11. Sica A, Schioppa T, Mantovani A et al. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy. Eur J Cancer 2006;42:717–727.
12. Talmadge JE, Donkor M Scholar E. Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer Metastasis Rev 2007;26:373–400.
13. Comito G, Giannoni E, Segura CP et al. Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression. Oncogene 2014;33:2423–2431.
14. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 2006;8:315–317.
15. Li M, Ikehara S. Bone-marrow-derived mesenchymal stem cells for organ repair. Stem Cells Int 2013;2013:132642.
16. Direkze NC, Forbes SJ, Brittan M et al. Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. Stem Cells 2003;21:514–520.
17. Spaeth E, Klopp A, Dembinski J et al. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther 2008;15:730–738.
18. Nakamizo A, Marini F, Amano T et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005;65:3307–3318.
19. Coffelt SB, Marini FC, Watson K et al. The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. Proc Natl Acad Sci USA 2009;106:3806–3811.
20. Zhang T, Lee YW, Rui YF et al. Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors. Stem Cell Res Ther 2013;4:70.
21. Studeny M, Marini FC, Champlin RE et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 2002;62:3603–3608.
22. Khakoo AY, Pati S, Anderson SA et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 2006;203:1235–1247.
23. Wu X, Hu J, Zhou L et al. In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory investigation. J Neurosurg 2008;108:320–329.
24. Otsu K, Das S, Houser SD et al. Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. Blood 2009;113:4197–4205.
25. Secchiero P, Zorzet S, Tripodo C et al. Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts. PLoS One 2010;5:e11140.
26. Ho IA, Toh HC, Ng WH et al. Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis. Stem Cells 2013;31:146–155.
27. Wang ML, Pan CM, Chiou SH et al. Oncostatin m modulates the mesenchymal-epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect. Cancer Res 2012;72:6051–6064.
28. Mishra PJ, Humeniuk R, Medina DJ et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 2008;68:4331–4339.
29. Au P, Tam J, Fukumura D et al. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 2008;111:4551–4558.
30. Bexell D, Gunnarsson S, Tormin A et al. Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol Ther 2009;17:183–190.
31. Ye H, Cheng J, Tang Y et al. Human bone marrow-derived mesenchymal stem cells produced TGFbeta contributes to progression and metastasis of prostate cancer. Cancer Invest 2012;30:513–518.
32. Dotor J, López-Vázquez AB, Lasarte JJ et al. Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library. Cytokine 2007;39:106–115.
33. Margheri F, Schiavone N, Papucci L et al. GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides. PLoS One 2012;7:e50342.
34. Smith PK, Krohn RI, Hermanson GT et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76–85.
35. Birnbaum T, Hildebrandt J, Nuebling G et al. Glioblastoma-dependent differentiation and angiogenic potential of human mesenchymal stem cells in vitro. J Neurooncol 2011;105:57–65.
36. Suzuki K, Sun R, Origuchi M et al. Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol Med 2011;17:579–587.
37. Schichor C, Birnbaum T, Etminan N et al. Vascular endothelial growth factor a contributes to glioma-induced migration of human marrow stromal cells (hMSC). Exp Neurol 2006;199:301–310.
38. San Francisco IF, DeWolf WC, Peehl DM et al. Expression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblasts. Int J Cancer 2004;112:213–218.
39. Karnoub AE, Dash AB, Vo AP et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449:557–563.
40. Laurenzana A, Biagioni A, Bianchini F et al. Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells. J Mol Med (Berl) 2015;93:783–794.
41. Shinagawa K, Kitadai Y, Tanaka M et al. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer. Int J Cancer 2013;132:813–823.
42. Orimo A, Gupta PB, Sgroi DC et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005;121:335–348.
43. Cao Q, Wang Y, Zheng D et al. IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis. J Am Soc Nephrol 2010;21:933–942.
44. Fiaschi T, Giannoni E, Taddei ML et al. Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells. Cell Cycle 2013;12:1791–1801.
45. Duda DG, Duyverman AM, Kohno M et al. Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci USA 2010;107:21677–21682.
46. Fiaschi T, Chiarugi P. Oxidative stress, tumor microenvironment, and metabolic reprogramming: A diabolic liaison. Int J Cell Biol 2012;2012:762825.
47. Charbord P. Bone marrow mesenchymal stem cells: Historical overview and concepts. Hum Gene Ther 2010;21:1045–1056.
48. Dwyer RM, Potter-Beirne SM, Harrington KA et al. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res 2007;13:5020–5027.
49. Gutova M, Najbauer J, Frank RT et al. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors. Stem Cells 2008;26:1406–1413.
50. Barcellos-de-Souza P, Gori V, Bambi F et al. Tumor microenvironment: Bone marrow-mesenchymal stem cells as key players. Biochim Biophys Acta 2013;1836:321–335.
51. Bergfeld SA, DeClerck YA. Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev 2010;29:249–261.
52. Wilding G, Zugmeier G, Knabbe C et al. Differential effects of transforming growth factor beta on human prostate cancer cells in vitro. Mol Cell Endocrinol 1989;62:79–87.
53. Blanchère M, Saunier E, Mestayer C et al. Alterations of expression and regulation of transforming growth factor beta in human cancer prostate cell lines. J Steroid Biochem Mol Biol 2002;82:297–304.
54. Massagué J. TGFbeta in Cancer. Cell 2008;134:215–230.
55. Shangguan L, Ti X, Krause U et al. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects. Stem Cells 2012;30:2810–2819.
56. Jung Y, Kim JK, Shiozawa Y et al. Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis. Nat Commun 2013;4:1795.
57. El-Helou V, Gosselin H, Villeneuve L et al. The plating of rat scar myofibroblasts on matrigel unmasks a novel phenotype; the self assembly of lumen-like structures. J Cell Biochem 2012;113:2442–2450.